Are the Newest Angiotensin Receptor Blockers Preferred than the Old Members in COVID-19 Patients with Cardiovascular Comorbidity?

Hussam A.S. Murad, Suleiman S. Al-Kayyal and Turky A. Alkaabi

International Journal of Pharmacology 17 ( 7 ): 435 - 441 , 2021